NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDVenetoclax 10mg, 50mg, 100mg Venclyxto®
(Tablets) 		Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Venetoclax  Venetoclax [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Antineoplastics, Other
Targeted Therapy Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA1119: Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia
NICE TA487: Venetoclax for treating chronic lymphocytic leukaemia
NICE TA561: Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia
NICE TA663: Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia
NICE TA765: Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
NICE TA787 Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
NICE TA787: Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
NICE TA796: Venetoclax for treating chronic lymphocytic leukaemia
NICE TA891: Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia